Skip to content
back
back
back
back
back

Our financial data in facts & figures

OUR REVENUES

EBITDA (2023)
90,4 (19,5% of turnover)
EBIT (2023)
66,4 (14,3% of turnover)
NET RESULT (2023)
45,2 (9,8% of turnover)

Related papers

OUR FIGURES BY FOCUS AREA (%, 2023)
34,92 %
JOINT CARE
20,5 %
EYE CARE
13,69 %
SKIN CARE
13,67 %
PRIMARY CARE
6,76 %
SPECIALTY CARE
1,77 %
REGENERATIVE CARE
0,95 %
AESTHETIC CARE
7,74 %
OTHER
OUR FIGURES BY PRODUCT CATEGORY (€ Millions, 2023)
43 %
MEDICAL DEVICES
40 %
PRESCRIPTION DRUGS
4 %
VACCINES
13 %
OTHER
OUR FIGURES BY GEOGRAPHICAL AREA (%, 2023)
51,7 %
ITALY
23,3 %
EUROPE
12 %
USA
4,8 %
MENA
8,2 %
RoW

OUR GROUP

GOVERNANCE
Find out more